Creo Medical Group PLC
LSE:CREO

Watchlist Manager
Creo Medical Group PLC Logo
Creo Medical Group PLC
LSE:CREO
Watchlist
Price: 10.13 GBX -2.36% Market Closed
Market Cap: 41.8m GBX

Profitability Summary

Creo Medical Group PLC's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

Analyzing past growth in Revenue, Operating Income, and Net Income allows investors to assess the company's profitability and operational efficiency. Consistent improvement in these metrics typically signals long-term strength and stability.

Show More Less

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Show More Less

Earnings Waterfall
Creo Medical Group PLC

Revenue
2.2m GBP
Cost of Revenue
-1.2m GBP
Gross Profit
1m GBP
Operating Expenses
-11m GBP
Operating Income
-10m GBP
Other Expenses
26.9m GBP
Net Income
16.9m GBP

Margins Comparison
Creo Medical Group PLC Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
UK
Creo Medical Group PLC
LSE:CREO
41.8m GBP
45%
-455%
768%
US
Abbott Laboratories
NYSE:ABT
218.2B USD
56%
18%
32%
US
Intuitive Surgical Inc
NASDAQ:ISRG
194.4B USD
66%
29%
29%
US
Boston Scientific Corp
NYSE:BSX
137.2B USD
69%
19%
14%
US
Stryker Corp
NYSE:SYK
134.9B USD
65%
22%
12%
IE
Medtronic PLC
NYSE:MDT
128B USD
66%
19%
14%
DE
Siemens Healthineers AG
XETRA:SHL
49.2B EUR
39%
14%
9%
US
Becton Dickinson and Co
NYSE:BDX
57.3B USD
46%
16%
8%
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55.8B USD
62%
31%
25%
US
Edwards Lifesciences Corp
NYSE:EW
48.5B USD
78%
28%
23%
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
38.2B USD
41%
14%
11%
No Stocks Found

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Show More Less

Return on Capital Comparison
Creo Medical Group PLC Competitors

Country Company Market Cap ROE ROA ROCE ROIC
UK
Creo Medical Group PLC
LSE:CREO
41.8m GBP
31%
24%
-16%
-21%
US
Abbott Laboratories
NYSE:ABT
218.2B USD
31%
18%
12%
20%
US
Intuitive Surgical Inc
NASDAQ:ISRG
194.4B USD
17%
15%
17%
22%
US
Boston Scientific Corp
NYSE:BSX
137.2B USD
13%
7%
11%
9%
US
Stryker Corp
NYSE:SYK
134.9B USD
14%
6%
14%
12%
IE
Medtronic PLC
NYSE:MDT
128B USD
10%
5%
8%
7%
DE
Siemens Healthineers AG
XETRA:SHL
49.2B EUR
12%
5%
10%
6%
US
Becton Dickinson and Co
NYSE:BDX
57.3B USD
7%
3%
7%
6%
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55.8B USD
65%
31%
58%
35%
US
Edwards Lifesciences Corp
NYSE:EW
48.5B USD
14%
10%
14%
16%
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
38.2B USD
24%
6%
11%
8%
No Stocks Found

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Show More Less